Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation - Concepedia

Concepedia

Publication | Open Access

Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation

DOI Full Paper Access

40

Citations

24

References

2007

Year

Lesley Tilson, L Thornton, D O’Flanagan, Howard Johnson, Michael Barry

European Journal of Public Health

Abstract

At a cost of euro29.00 per dose of the six-component vaccine, universal infant hepatitis B vaccination is cost effective at euro37 018/LYG. This compares favourably with other preventive programmes in Ireland.

References

	Year	Citations
Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease Andrew Briggs, Ron Goeree, G. Blackhouse, Medical Decision Making Cost-effectiveness PlaneDecision ScienceSurgeryCost-effectiveness FrontierExclusive Treatment Options	2002	360
Prevention of Hepatitis B Virus Transmission by Immunization Harold S. Margolis JAMA	1995	308
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants David W. Fitzsimons, Guido François, Andrew J. Hall, Vaccine VaccinationBooster PolicyVaccine DevelopmentLong-term EfficacyViral Hepatitis	2005	179
A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness Analysis Bernard S. Bloom Annals of Internal Medicine	1993	162
Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model Rakesh Aggarwal, Uday C. Ghoshal, S. R. Naik Journal of Hepatology VaccinationIntermediate EndemicityHealth EconomicsViral HepatitisHepatitis B	2003	78
Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. Murray Krahn, Roland Guasparini, Morris Sherman, American Journal of Public Health	1998	64
Hepatitis B prevention in Europe: a preliminary economic evaluation Pierre Van Damme, G. Tormans, Philippe Beutels, Vaccine Preventive MedicineHealth EconomicsViral HepatitisDisease PreventionHepatitis B	1995	52
Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales. Punam Mangtani, A. Hall, Charles Normand Journal of Epidemiology & Community Health	1995	50
Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age Irmingard Tichmann, Helmut Preidel, Detlef Grunert, Vaccine VaccinationVaccine SafetyVaccinologyVaccine DevelopmentAllergy	2005	42
The Cost Effectiveness of Hepatitis Immunization for US College Students R. Jake Jacobs, Sammy Saab, Allen S. Meyerhoff Journal of American College Health VaccinationVaccinologyVaccine SafetyPreventive MedicineInfectious Disease Prevention	2003	39

Page 1